Renewed hope for treatment of pain and depression

(Luxembourg Institute of Health) Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby modulating the levels of opioid peptides produced in the central nervous system (CNS) and potentiating their natural painkilling and antidepressant properties. These findings were published on June 19th in the prestigious international journal 'Nature Communications'.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news